Genentech (NYSE:DNA) formerly known as (NYSE:GNE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

DNA 8.400

-5.7%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (122)	1/6/2007 1:39:21 AM
From: tuck	Read Replies (1) of 250

>>Genentech is not only an A+ biotech but also deserves kudos for symantecs<< You're saying their network security is good? Whatever, Dew may be right that somebody mistranslated something wrt to the phrase "estimating progression-free survival." In any case, Omnitarg was left for dead, so if they can salvage it, fine. However, the market seems to think it has ALREADY salvaged it despite this murkiness. A couple of weeks ago I was thinking of writing DNA puts. Early this week I was bemoaning the fact that I hadn't. Now DNA seems priced a little high given the uncertainty. Let's just say I would have bought back my puts today, had I sold them. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next